These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30619356)

  • 1. Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.
    May O; Merle NS; Grunenwald A; Gnemmi V; Leon J; Payet C; Robe-Rybkine T; Paule R; Delguste F; Satchell SC; Mathieson PW; Hazzan M; Boulanger E; Dimitrov JD; Fremeaux-Bacchi V; Frimat M; Roumenina LT
    Front Immunol; 2018; 9():3008. PubMed ID: 30619356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.
    Frimat M; Tabarin F; Dimitrov JD; Poitou C; Halbwachs-Mecarelli L; Fremeaux-Bacchi V; Roumenina LT
    Blood; 2013 Jul; 122(2):282-92. PubMed ID: 23692858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of von Willebrand factor in thrombotic microangiopathy.
    Noone DG; Riedl M; Licht C
    Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
    Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
    J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.
    Merle NS; Paule R; Leon J; Daugan M; Robe-Rybkine T; Poillerat V; Torset C; Frémeaux-Bacchi V; Dimitrov JD; Roumenina LT
    Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6280-6285. PubMed ID: 30850533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of C5aR and C5b-9 pathways to renal thrombic microangiopathy and macrovascular thrombosis in mice carrying an atypical hemolytic syndrome-related factor H mutation.
    Ueda Y; Miwa T; Ito D; Kim H; Sato S; Gullipalli D; Zhou L; Golla M; Song D; Dunaief JL; Palmer MB; Song WC
    Kidney Int; 2019 Jul; 96(1):67-79. PubMed ID: 30910380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
    Aradottir SS; Kristoffersson AC; Roumenina LT; Bjerre A; Kashioulis P; Palsson R; Karpman D
    Front Immunol; 2021; 12():690821. PubMed ID: 34177949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolysis is associated with altered heparan sulfate of the endothelial glycocalyx and with local complement activation in thrombotic microangiopathies.
    Laboux T; Maanaoui M; Allain F; Boulanger E; Denys A; Gibier JB; Glowacki F; Grolaux G; Grunenwald A; Howsam M; Lancel S; Lebas C; Lopez B; Roumenina L; Provôt F; Gnemmi V; Frimat M
    Kidney Int; 2023 Aug; 104(2):353-366. PubMed ID: 37164260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.
    Sartain SE; Turner NA; Moake JL
    J Biol Chem; 2018 May; 293(19):7195-7208. PubMed ID: 29555686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation.
    Chen JY; Galwankar NS; Emch HN; Menon SS; Cortes C; Thurman JM; Merrill SA; Brodsky RA; Ferreira VP
    Front Immunol; 2020; 11():1460. PubMed ID: 32793201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome.
    Magro CM; Momtahen S; Mulvey JJ; Yassin AH; Kaplan RB; Laurence JC
    Am J Dermatopathol; 2015 May; 37(5):349-56; quiz 357-9. PubMed ID: 25893747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells.
    Sartain SE; Turner NA; Moake JL
    J Immunol; 2016 Jan; 196(2):832-45. PubMed ID: 26673143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.
    Smith-Jackson K; Yang Y; Denton H; Pappworth IY; Cooke K; Barlow PN; Atkinson JP; Liszewski MK; Pickering MC; Kavanagh D; Cook HT; Marchbank KJ
    J Clin Invest; 2019 Mar; 129(3):1061-1075. PubMed ID: 30714990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D; Yu XJ; Wang FM; Xu BN; He YD; Chen Q; Wang SX; Yu F; Song WC; Zhao MH
    Am J Reprod Immunol; 2015 Oct; 74(4):345-56. PubMed ID: 26011580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin.
    Kinderlerer AR; Pombo Gregoire I; Hamdulay SS; Ali F; Steinberg R; Silva G; Ali N; Wang B; Haskard DO; Soares MP; Mason JC
    Blood; 2009 Feb; 113(7):1598-607. PubMed ID: 19036700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera.
    Pouw RB; Brouwer MC; de Gast M; van Beek AE; van den Heuvel LP; Schmidt CQ; van der Ende A; Sánchez-Corral P; Kuijpers TW; Wouters D
    Blood Adv; 2019 Feb; 3(4):621-632. PubMed ID: 30804016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
    Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin and Endothelial Dysfunction: A Disease-Modifier Shared between Malignant Hypertension and Atypical Hemolytic Uremic Syndrome.
    Demeulenaere M; Devreese K; Vanbelleghem H; De Zaeytijd J; Vande Walle J; Van Biesen W; Van Laecke S
    Nephron; 2018; 140(1):63-73. PubMed ID: 29940557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin
    Wijnsma KL; Veissi ST; de Wijs S; van der Velden T; Volokhina EB; Wagener FADTG; van de Kar NCAJ; van den Heuvel LP
    Front Immunol; 2020; 11():547406. PubMed ID: 33414780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.